SCHEMBL7810409

SCHEMBL7810409

CCOC(=O)C(F)(F)Cc1ccccn1

nearest known ligand 0.48

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.45
KDM4E B2RXH2 1/20 0.45
FDPS P14324 1/20 0.44
LMNA P02545 3/20 0.43
TRPM8 Q7Z2W7 1/20 0.42
GAA P10253 2/20 0.42
TSHR P16473 2/20 0.42
SMN1; SMN2 Q16637 3/20 0.42
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
POLB P06746 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
RAB9A P51151 2/20 0.41
PIN1 Q13526 1/20 0.41
NPC1 O15118 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5862781 0.85 ALDH1A1 (0.47) ALDH1A1KDM4EFDPSLMNATRPM8
SCHEMBL5140898 0.85 CYP1A2 (0.48) ALDH1A1KDM4EFDPSLMNATRPM8
SCHEMBL15931181 0.80 KDM4E (0.41) ALDH1A1KDM4ELMNAGAATSHR
SCHEMBL5861527 0.79 RAB9A (0.46) ALDH1A1KDM4EFDPSLMNATRPM8
SCHEMBL5861519 0.78 TRPM8 (0.47) ALDH1A1KDM4EFDPSLMNATRPM8
SCHEMBL5861486 0.78 ALDH1A1 (0.65) ALDH1A1KDM4ETSHRSMN1; SMN2MEN1
SCHEMBL7810653 0.78 FDPS (0.51) ALDH1A1KDM4EFDPSLMNAGAA
SCHEMBL5860443 0.77 L3MBTL1 (0.41) ALDH1A1KDM4EFDPSLMNATRPM8
SCHEMBL27807473 0.77 ALDH1A1 (0.41) ALDH1A1KDM4EFDPSLMNATRPM8
SCHEMBL18404733 0.77 POLB (0.45) KDM4ELMNAGAATSHRSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0694546-B1 Substituted dibenzoxazepine compounds, pharmaceutical compositions and use SEARLE & CO (US) 2001-06-06 EP disclosed
EP-0694545-B1 Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use SEARLE & CO (US) 2000-07-26 EP disclosed
US-5576315-A Substituted dibenzoxazepine compounds and methods for treating osteoporosis and ischemia G.D. SEARLE & CO. (US) 1996-11-19 US disclosed
EP-0694545-A2 Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use G.D. SEARLE & CO. (US) 1996-01-31 EP disclosed
EP-0694546-A2 Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use G.D. SEARLE & CO. (US) 1996-01-31 EP disclosed
US-5464830-A ANALGESICS G. D. SEARLE & CO. (US) 1995-11-07 US disclosed
US-5378840-A Substituted dibenzoxazepine compounds G. D. SEARLE & CO. (US) 1995-01-03 US disclosed
WO-1992019617-A2 SUBSTITUTED DIBENZOXAZEPINE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE G.D. SEARLE & CO. (US) 1992-11-12 WO disclosed
EP-0512400-A1 Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use G.D. Searle & Co. (US) 1992-11-11 EP disclosed